Notably, CW069 treatment resulted in a greater decrease (~ 4 fold) in tumor volume in mice bearing AR-TNBC tumors than in those with AR + TNBC (~ 1.5 fold; (Fig. 7B, D–E). Here, AR is linked to neoplasm.